click below
click below
Normal Size Small Size show me how
HIV drugs 218
| Question | Answer |
|---|---|
| HAART | 2 NRTI + 1 nnrti or 1 protease inhibitor OR 1 integrase inhibitor |
| integrase inhibitor | raltegravir |
| raltegravir | inhibits HIV genome integration into host cell chromosome by reversibly inhibiting HIV integrase |
| Raltegravir SE | hypecholesterolemia |
| NNRTI's | tenofovir emtricitabine abacavir lamivudine zidovudine didanosine |
| stavudine | NRTI hepativ steatosis |
| didanosine | NRTI pancreatitis peripheral neuropahty |
| zidovudine | bone marrow suppression peripheral neuropathy megaloblastic anemia |
| abacavir | rash |
| peripheral neuropathy | didanosine stavudine |
| megaloblastic anemia | zidovudine |
| rash | NNRTI - nevirapine, efavirenz, delaviridine |
| hyperglycemia, DM, lipid abnormalities | sawuinavir, ritonavir, amprenavir protease inhibitors |
| protease inhibitors | assembly of virions depends on HIV 1 protease (pol gene), which cleaves the polypeptide products of HIV mRNA into their functional parts. THus, protease inhbitiors prevent maturation of new viruses. |
| rinavir | can boost other drug concentrations by inhibitng cytochrome P450 |
| NRTI | competitively inhibit nucleotide binding to reverse transcriptase and terminate the DNA chain (lack a 3OH group |
| NRTI | must be phosphrylated by thymidine kinase to be active |
| pregnancy in HIV | zidovudine |
| NNRTI | bind to reverse transcriptase at site different from NRTI. Do not require phosphrylation to be active or compete with nucleotides |
| integrase inhibitor | inhibits HIV genome integration into host cell chromsome by reversibly inhibiting HIV integrase |